ArticleClinical and experimental immunology2023

A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models.

Somi Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.